Annelies Grimonprez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Annelies Grimonprez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Paul Boon
Brain, Department of Head and Skin, Ghent University, Ghent, Belgium
3 shared publications - Robrecht Raedt
BRAIN, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium
3 shared publications - Kristl Vonck
Brain, Department of Neurology, Ghent University Hospital, Ghent, Belgium
2 shared publications - Lars Emil Larsen
BRAIN, Department of Head and Skin, Ghent University, 9000 Ghent, Belgium
2 shared publications Alfred Meurs
Laboratory for Clinical and Experimental Neurophysiology, Neurobiology and Neuropsychology (LCEN3), Ghent University, Department of Neurology, Institute for Neuroscience, Ghent, Belgium
1 shared publication- Alfred Meurs
Laboratory for Clinical and Experimental Neurophysiology, Ghent University Hospital, Ghent, Belgium
1 shared publication
Latest Publications
- 1 September 2015
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 56, 26-34
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
- 1 September 2015
- Published by Elsevier in Neuroscience & Biobehavioral Reviews
- Vol. 56, 26-34
The antidepressant mechanism of action of vagus nerve stimulation: Evidence from preclinical studies
- 1 September 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 68, 1-7
The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus
- 1 September 2015
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 68, 1-7
The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus
- 1 January 2015
- Published by Elsevier in Brain Stimulation
- Vol. 8 (1) , 13-20
Vagus Nerve Stimulation has Antidepressant Effects in the Kainic Acid Model for Temporal Lobe Epilepsy
- 1 January 2015
- Published by Elsevier in Brain Stimulation
- Vol. 8 (1) , 13-20
Vagus Nerve Stimulation has Antidepressant Effects in the Kainic Acid Model for Temporal Lobe Epilepsy
- Open Access
- 1 January 2014
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 8
Dose-dependent laryngeal muscle evoked potentials as an indicator of effective vagus nerve stimulation
Rationale| Vagus nerve stimulation (VNS) is a neuromodulatory treatment for refractory epilepsy and depression. The major drawbacks of VNS are 1/ the lack of response in a third of patients and 2/ the fact that the optimal stimulation parameters are unknown. Vagal nerve recordings in both an experimental and clinical setting may be useful to overcome these drawbacks. In this study, VNS-induced laryngeal muscle evoked potentials (LMEPs) were recorded in rats as a biomarker for effective activation of the vagus nerve. Methods| Rats (n=18) were implanted with a bipolar stimulation cuff-electrode around the left vagus nerve. After at least two weeks of recovery, VNS-induced LMEPs were recorded under anesthesia using a monopolar EMG needle electrode placed subcutaneously near the laryngeal muscles and a distant reference electrode on the skull of the rat. Biphasic VNS pulses of 250 µs per phase were used. The output current of the pulses was gradually ramped-up from 0.1 mA to 1.0 mA in steps op 0.1 mA. For each intensity, 20 sweeps were averaged to improve the signal to noise ratio. Results| VNS-induced LMEPs were reproducibly recorded in 16/18 rats. The LMEPs were characterized by a negative peak with a latency of 2.6 ms ± 0.9 ms after the onset of the stimulation pulse. The threshold for evoking LMEPs was variable, ranging from 0.1 mA to 0.7 mA (0.4 mA ± 0.2 mA). Conclusion| This minimally invasive technique could be used both in animal studies and in clinical practice 1/ to identify non-responders due to inactivity of the vagus nerve and 2/ to determine individual stimulation parameter requirements for efficient activation of the vagus nerve. Short comment: Nervus vagus stimulatie is een behandeling voor epilepsiepatiënten die geen baat hebben bij medicatie. Twee nadelen van de therapie zijn dat 1/ een derde van de patiënten geen effect ervaart, mogelijks doordat de zenuw niet geactiveerd wordt en 2/ dat de optimale stimulatieparameters niet gekend zijn. In deze studie werd een techniek geoptimaliseerd om na te gaan of de nervus vagus effectief geactiveerd wordt bij verschillende nervus vagus stimulatie intensiteiten in ratten. Deze techniek zou getest kunnen worden bij patiënten om 1/ na te gaan of de zenuw effectief geactiveerd wordt en 2/om de stimulatie parameters per patiënt te optimaliseren.
- 1 January 2014
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 8
Open AccessDose-dependent laryngeal muscle evoked potentials as an indicator of effective vagus nerve stimulation
Rationale| Vagus nerve stimulation (VNS) is a neuromodulatory treatment for refractory epilepsy and depression. The major drawbacks of VNS are 1/ the lack of response in a third of patients and 2/ the fact that the optimal stimulation parameters are unknown. Vagal nerve recordings in both an experimental and clinical setting may be useful to overcome these drawbacks. In this study, VNS-induced laryngeal muscle evoked potentials (LMEPs) were recorded in rats as a biomarker for effective activation of the vagus nerve. Methods| Rats (n=18) were implanted with a bipolar stimulation cuff-electrode around the left vagus nerve. After at least two weeks of recovery, VNS-induced LMEPs were recorded under anesthesia using a monopolar EMG needle electrode placed subcutaneously near the laryngeal muscles and a distant reference electrode on the skull of the rat. Biphasic VNS pulses of 250 µs per phase were used. The output current of the pulses was gradually ramped-up from 0.1 mA to 1.0 mA in steps op 0.1 mA. For each intensity, 20 sweeps were averaged to improve the signal to noise ratio. Results| VNS-induced LMEPs were reproducibly recorded in 16/18 rats. The LMEPs were characterized by a negative peak with a latency of 2.6 ms ± 0.9 ms after the onset of the stimulation pulse. The threshold for evoking LMEPs was variable, ranging from 0.1 mA to 0.7 mA (0.4 mA ± 0.2 mA). Conclusion| This minimally invasive technique could be used both in animal studies and in clinical practice 1/ to identify non-responders due to inactivity of the vagus nerve and 2/ to determine individual stimulation parameter requirements for efficient activation of the vagus nerve. Short comment: Nervus vagus stimulatie is een behandeling voor epilepsiepatiënten die geen baat hebben bij medicatie. Twee nadelen van de therapie zijn dat 1/ een derde van de patiënten geen effect ervaart, mogelijks doordat de zenuw niet geactiveerd wordt en 2/ dat de optimale stimulatieparameters niet gekend zijn. In deze studie werd een techniek geoptimaliseerd om na te gaan of de nervus vagus effectief geactiveerd wordt bij verschillende nervus vagus stimulatie intensiteiten in ratten. Deze techniek zou getest kunnen worden bij patiënten om 1/ na te gaan of de zenuw effectief geactiveerd wordt en 2/om de stimulatie parameters per patiënt te optimaliseren.